购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-30(compound 64)作为一种有效的hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 抑制剂,该化合物在使用雌二醇作底物时,IC50 值低于0.1 μM。此外,HSD17B13-IN-30 对于研究包括NASH(非酒精性脂肪性肝炎)在内的非酒精性脂肪肝疾病 (NAFLD) 具有重要的作用。
HSD17B13-IN-30(compound 64)作为一种有效的hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 抑制剂,该化合物在使用雌二醇作底物时,IC50 值低于0.1 μM。此外,HSD17B13-IN-30 对于研究包括NASH(非酒精性脂肪性肝炎)在内的非酒精性脂肪肝疾病 (NAFLD) 具有重要的作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-30 (compound 64) serves as a potent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 value of less than 0.1 μM? with estradiol? as substrates. This compound is significantly implicated in the management of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1]. |
分子量 | 538.3 |
分子式 | C24H16Cl2F3N3O4 |
CAS No. | 2770246-58-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容